PZ Wind Down Inc. Stock Analysis PZRXQ
PhaseRx, Inc. operates as a bio pharmaceutical company that develops a portfolio of mRNA products to correct inherited, life-threatening liver diseases in children. The firm's initial product development focus is on urea cycle disorders, a group of rare genetic diseases that generally present before the age of 12 and are characterized by the body's inability to remove ammonia from the blood. The firm's i-ERT approach is enabled by its Hybrid mRNA Technology platform and is applicable to a number of inherited liver diseases. The firm is headquartered in Seattle.
Read More PZ Wind Down Inc (PZRXQ) Chart
Financial Metrics & Statements of PZ Wind Down Inc (PZRXQ)
FAQ's for PZ Wind Down Inc (PZRXQ)
- According to Musaffa’s Shariah screening methodology, PZ Wind Down Inc (PZRXQ) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.